CROI 2024 BHIVA working group summary

Tristan J Barber; Amanda Clarke; Ashini Fox; Nicola E Mackie; Caroline Sabin; Laura J Waters

doi:10.1111/hiv.13705

CROI 2024 BHIVA working group summary

HIV Med. 2024 Sep 10. doi: 10.1111/hiv.13705. Online ahead of print.

Authors

Tristan J Barber^{1

2}, Amanda Clarke^{3

4}, Ashini Fox⁵, Nicola E Mackie⁶, Caroline Sabin², Laura J Waters^{2

7}

Affiliations

¹ Department of HIV Medicine, Royal Free London NHS Foundation Trust, London, UK.
² Institute for Global Health, University College London, London, UK.
³ University Hospitals Sussex NHS Foundation Trust, Brighton, UK.
⁴ Brighton and Sussex Medical School, Brighton, UK.
⁵ Nottingham University Hospitals NHS Trust, Nottingham, UK.
⁶ Imperial College Healthcare NHS Trust, London, UK.
⁷ Department of Sexual Health & HIV, Central and Northwest London NHS Foundation Trust, London, UK.

PMID: 39257023
DOI: 10.1111/hiv.13705

Abstract

The Conference on Retroviruses and Opportunistic Infections (CROI) is usually the most significant HIV conference of the year in terms of basic and clinical scientific output. CROI 2024 in Denver, USA, felt very much back to 'business as usual' following COVID-19 disruptions that had impacted preceding years, but also felt more global and outward- facing. The British HIV Association supports a working group to attend CROI annually and deliver feedback in the UK. This article summarizes the highlights from that meeting.

Keywords: CROI; HIV.

Publication types

Review